Skip to main content
OpenTrials
Completed

NCT Number: NCT05322278

Obstetric Outcomes After Double Embryo Transfer

Aim ; to compare obstetric outcomes in relation to number of embryo transfer in ICSI

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Assiut University

Asyut, Egypt

About this study

Assisted reproductive technology with intracytoplasmic sperm injection (ICSI) and IVF is becoming an international direction for couples struggling with infertility. The increasing popularity and frequency of these techniques and the data generated from it has given us a better overview of the efficacy, consequences and costs of these techniques.

The aim of assisted reproductive technology (ART) is to achieve pregnancy while decreasing the risk of multiple gestations. When compared with elective single embryo transfer (SET), double embryo transfer (DET) demonstrates a superior pregnancy and live birth rate with a significantly higher risk of multiple gestations. The high frequency of multiple births is the main factor which leads to adverse outcome in IVF/intracytoplasmic sperm injection (ICSI) treatment. Transfer of two embryos does not diminish the chance of a birth when compared with three embryo transfer. How would be the obstetric outcome in pregnancies resulting from DET in IVF/ICSI cycles.

Despite achieving a higher pregnancy rates, DET in ART leads to an increase in multiple gestation pregnancies, which are associated with increased both maternal and neonatal morbidity and mortality.

Twin pregnancies have a higher incidence of preterm cesarean sections , admissions to the neonatal intensive care unit (NICU), and other maternal complications, when compared with singleton pregnancies. Twin pregnancies have a higher incidence of preterm cesarean sections , admissions to the neonatal intensive care unit (NICU), and other maternal complications, when compared with singleton pregnancies.

Most patients prefer to have two embryos transferred, due to financial considerations being the main reason.

Studies demonstrate that patients are more likely prefer to choose SET when educated about the risks of multiple gestation pregnancy, but select two embryos for transfer if they have a lower pregnancy rate when compared with transferring one embryo .

Cost effectiveness research comparing single versus DET after in vitro fertilization (IVF) has previously been performed, with most studies taking place in areas with mandated IVF insurance coverage, and few incorporating hospital costs linked to obstetrical and neonatal outcomes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients subjected with ICSI pregnancy

Exclusion criteria

  • incomplete data

Treatment and study plan

Data Collection

Other

No interventions

Primary outcomes

  1. Live birth

    Time frame: 1 year

    Comparison

Secondary outcomes

  1. Rate of miscarriage

    Time frame: 1 year

    Comparison

  2. Rate of neonatal morbidities and mortalities in single embryo transfer versus double embryo transfer

    Time frame: 1 year

    Comparison

  3. Rate of admission to NICU

    Time frame: 1 year

    Comparison

  4. Rate of multiple pregnancies

    Time frame: 1 year

    Comparison

  5. Rate of preterm

    Time frame: 1 year

    Comparison

  6. Rate of PPROM

    Time frame: 1 year

    Comparison

  7. Rate of Clinical pregnancy

    Time frame: 1 year

    Comparison

  8. Rate of chemical pregnancy

    Time frame: 1 year

    Comparison

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Obstetric Outcomes After Double Embryo Transfer in Intracytoplasmic Sperm Injection

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Apr 11, 2022
Registry last updated
Jun 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.